Aidar Health Company

At Aidar Health, they have developed a rapid health assessment device, MouthLab, that can measure COVID-19 symptoms early and monitor patients at home or in the hospital. It works like a breathalyzer, but acts like a Star Trek tri-corder. When a patient breathes into the device’s mouthpiece for 30 seconds it captures more than 10 vital medical parameters. Today, only a digital thermometer is used as a sole predictor of infection or disease status with low sensitivity. But, COVID-19 detection and management need additional digital biomarkers that are currently undetected or under-utilized. With MouthLab, early COVID-19 symptoms such as fever, cough and shortness of breath can be measured in real-time using their thermometer, and breath sensors that measure breathing rate, coughing patterns and respiratory flow cycle morphology to assess shortness of breath. On the other hand, progressive disease symptoms include lung congestion (measured using MouthLab’s spirometer/lung function test) — due to lung infection, reduction in SpO2 (measured using MouthLab’s pulse Ox) — due to impaired gas diffusion between the lungs and blood, and irregular heart rhythms (measured using MouthLab’s ECG electrodes). Additionally, progressively worsening symptoms can be accurately captured by analyzing the downward trend in BP (measured using MouthLab’s bp sensors), hinting towards sepsis.
Technology: COVID
Industry: Preventive Tech
Headquarters: United States
Founded Date: N/A
Employees Number: N/A
Funding Status: N/A

Visit Website
Register and Claim Ownership